[What are at present the real hopes of pregnancy after ovarian cryopreservation?].
Survival rates for cancers that occur in childhood and adolescence have improved over the last decades, and preservation of future fertility in these patients has become a relevant issue. Premature ovarian failure is a consequence of exposing women to chemotherapeutic drugs and ionizing radiation. Ovarian cryopreservation is an alternative to cryopreservation of embryos or oocytes for theses patients. Ovarian cryopreservation aims to reimplant ovarian tissue after complete remission into the pelvic cavity (orthotopique site) or a heterotopic site like the abdominal wall or the forearm. In vitro folliculogenesis, that aims at the maturation of ovarian cortex primordial follicles cryopreserved for a FIV, is still in an experimental research stage. In this review, the objective was to evaluate the real hopes of pregnancy after ovarian cryopreservation. Indeed, many teams offer ovarian cryopreservation at present time, although only two pregnancies have been achieved to date. In both cases, it can be discussed whether the fertilized oocyte originated from the transplant or from the native ovary. Furthermore, the potential for reintroduction of cancerous cells may limit this technique in cancers that are known to have a risk of ovarian dissemination. The hopes engendered by ovarian cryopreservation, but also its limits, must be explained to the patients before an ovarian surgery for cryopreservation.
Courbière
B
B
Service de Gynécologie-Obstétrique et Centre d'Assistance Médicale à la Procréation (AMP), Hôpital de La Conception, 147 Boulevard Baille, 13385 Marseille cedex 05, France. blandine.courbiere@ap-hm.fr
Provansal
M
M
Saias-Magnan
J
J
Guillemain
C
C
Noizet
A
A
Grillo
J-M
JM
Gamerre
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects; D015925:Cryopreservation; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy*; D009926:Organ Preservation; D006080:Ovarian Follicle / Q000502:physiology*; D010053:Ovary / Q000637:transplantation; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced; D011832:Radiation Injuries; D014021:Tissue Preservation / Q000379:methods*
D000970:Antineoplastic Agents